Related Experiment Videos

Haemodynamic effect of intravenous verapamil in controlled atrial fibrillation

Australian and New Zealand Journal of Medicine
|October 1, 1975
PubMed

Insights

Intravenous verapamil slowed heart rate and increased stroke volume in patients with atrial fibrillation. However, it did not regularize the R-R interval or significantly change cardiac output during rest or exercise.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Atrial fibrillation is a common arrhythmia affecting ventricular rate control.
  • Verapamil is a calcium channel blocker used in managing cardiac conditions.

Purpose of the Study:

  • To assess the haemodynamic effects of intravenous verapamil in digitalised patients with atrial fibrillation.
  • To examine the effect of verapamil on ventricular rate regularization during rest and exercise.

Main Methods:

  • Eight patients with atrial fibrillation, who were digitalised, were studied.
  • Haemodynamic parameters were measured at rest and during and after exercise.
  • Intravenous verapamil was administered.

Main Results:

  • A significant slowing of heart rate occurred at rest, during, and after exercise.
  • Stroke volume significantly increased, consistent with heart rate slowing.
  • Cardiac output remained unchanged.
  • Regularisation of the R-R interval was not observed despite heart rate slowing.

Conclusions:

  • Intravenous verapamil effectively slows heart rate and increases stroke volume in digitalised patients with atrial fibrillation.
  • Verapamil does not consistently regularize the ventricular rhythm in atrial fibrillation.
  • The haemodynamic effects of verapamil are significant for stroke volume and heart rate but not cardiac output in this patient group.

Related Concept Videos